Soligenix Inc - ESG Rating & Company Profile powered by AI
The webpage includes a Q&A section about Soligenix Inc. This ESG rating covers 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Industry, Innovation & Infrastructure' and 'Life below Water'. Full Sustainability assessment of Soligenix Inc can be reached by signing up for free.
Soligenix Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Soligenix Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Soligenix Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Soligenix Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Soligenix Inc report the average age of the workforce?
Sign up for free to unlockDoes Soligenix Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Soligenix Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Soligenix Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Soligenix Inc offer flexible work?
Sign up for free to unlockDoes Soligenix Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Soligenix Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Soligenix Inc conduct supply chain audits?
Sign up for free to unlockDoes Soligenix Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Soligenix Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Soligenix Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Soligenix Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Soligenix Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Soligenix Inc disclose water use targets?
Sign up for free to unlockDoes Soligenix Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Soligenix Inc have a product recall in the last two years?
Sign up for free to unlockDoes Soligenix Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Soligenix Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Soligenix Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Soligenix Inc disclose parental leave metrics?
Sign up for free to unlockDoes Soligenix Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Soligenix Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Soligenix Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Soligenix Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Soligenix Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Soligenix Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Soligenix Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Soligenix Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Soligenix Inc disclose its waste policy?
Sign up for free to unlockDoes Soligenix Inc report according to TCFD requirements?
Sign up for free to unlockDoes Soligenix Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Soligenix Inc disclose energy use targets?
Sign up for free to unlockDoes Soligenix Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Soligenix Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Soligenix Inc
These potential risks are based on the size, segment and geographies of the company.
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease; and SGX302 that is in Phase I/II clinical trial for the treatment of mild-to-moderate psoriasis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.